Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR‐ and type‐I IFN‐dependent and ‐independent pathways
Open Access
- 7 April 2008
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 38 (4), 1058-1064
- https://doi.org/10.1002/eji.200738013
Abstract
B cell activating factor (BAFF) plays a key role in promoting B lymphocyte activation. We investigated whether danger signals induce BAFF secretion by cultured salivary gland epithelial cells (SGEC), which are the target of primary Sjögren's syndrome, a prototypic systemic autoimmune disease. SGEC cultures were established from minor salivary glands obtained from ten patients with pSS or sicca symptoms. BAFF mRNA and protein were measured after stimulation of the different Toll-like receptors (TLR) by agonists or viruses. The expression of TLR2, –3, and –7 was detected in SGEC. Poly (I:C) (a synthetic TLR3 agonist) and reovirus-1 (a dsRNA virus) induced high expression of BAFF mRNA (multiplied by a factor of 246 ± 39 (SEM) and 347 ± 66, respectively) and of BAFF protein secretion (58.49 ± 4.34 pg/mL and 69.73 ± 5.67). Inhibition of both the endosomal (by chloroquine) and IFN (by anti-IFNAR antibody) pathways partly inhibited BAFF expression. Treatment with both dsRNA virus and poly (I:C) induced high levels of BAFF mRNA and protein expression by SGEC, through pathways dependent on and independent of TLR and dependent on and independent of IFN. BAFF induction by target organs of autoimmune diseases after viral infection may be a link between innate immunity and autoimmunity.Keywords
This publication has 26 references indexed in Scilit:
- B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signalingCurrent Opinion in Immunology, 2007
- Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictorsAnnals Of The Rheumatic Diseases, 2006
- Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndromeProceedings of the National Academy of Sciences, 2006
- Sjögren's syndromeThe Lancet, 2005
- Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjectsArthritis & Rheumatism, 2005
- B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: Longitudinal observationsArthritis & Rheumatism, 2003
- The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndromeAnnals Of The Rheumatic Diseases, 2003
- Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune ManifestationsThe Journal of Experimental Medicine, 1999
- BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell GrowthThe Journal of Experimental Medicine, 1999
- Ro/SS-A- and La/SS-B-reactive B lymphocytes in peripheral blood of patients with Sjögren's syndromeClinical and Experimental Immunology, 1999